174 related articles for article (PubMed ID: 20113893)
21. Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.
Schrappe M
Radiat Prot Dosimetry; 2008; 132(2):130-3. PubMed ID: 19017727
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
23. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
24. Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.
Ortega JJ; Ribera JM; Oriol A; Bastida P; González ME; Calvo C; Egurbide I; Hernández Rivas JM; Rivas C; Alcalá A; Besalduch J; Maciá J; Gardella S; Carnero M; Lite JM; Casanova F; Martinez M; Fontanillas M; Feliu E; San Miguel JF;
Haematologica; 2001 Jun; 86(6):586-95. PubMed ID: 11418367
[TBL] [Abstract][Full Text] [Related]
25. First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study.
Domenech C; Mercier M; Plouvier E; Puraveau M; Bordigoni P; Michel G; Benoit Y; Leverger G; Baruchel A; Bertrand Y
Eur J Cancer; 2008 Nov; 44(16):2461-9. PubMed ID: 18804997
[TBL] [Abstract][Full Text] [Related]
26. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
[TBL] [Abstract][Full Text] [Related]
27. Genetic alterations targeting lymphoid development in acute lymphoblastic leukemia.
Collins-Underwood JR; Mullighan CG
Curr Top Dev Biol; 2011; 94():171-96. PubMed ID: 21295687
[TBL] [Abstract][Full Text] [Related]
28. Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
Izraeli S
Br J Haematol; 2010 Oct; 151(2):119-31. PubMed ID: 20678159
[TBL] [Abstract][Full Text] [Related]
29. Treatment of lymphoblastic lymphoma in adults.
Sweetenham JW
Oncology (Williston Park); 2009 Nov; 23(12):1015-20. PubMed ID: 20017283
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomics of pediatric acute lymphoblastic leukemia.
Meeker ND; Yang JJ; Schiffman JD
Expert Opin Pharmacother; 2010 Jul; 11(10):1621-32. PubMed ID: 20429672
[TBL] [Abstract][Full Text] [Related]
31. Biology of childhood acute lymphoblastic leukemia.
Lo Nigro L
J Pediatr Hematol Oncol; 2013 May; 35(4):245-52. PubMed ID: 23612374
[TBL] [Abstract][Full Text] [Related]
32. Management strategies in acute lymphoblastic leukemia.
Rabin KR; Poplack DG
Oncology (Williston Park); 2011 Apr; 25(4):328-35. PubMed ID: 21618954
[TBL] [Abstract][Full Text] [Related]
33. Central nervous disease in pediatric patients during acute lymphoblastic leukemia (ALL): a review.
Jin MW; Xu SM; An Q
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6015-6019. PubMed ID: 30280785
[TBL] [Abstract][Full Text] [Related]
34. A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia.
Capria S; Molica M; Mohamed S; Bianchi S; Moleti ML; Trisolini SM; Chiaretti S; Testi AM
Expert Rev Hematol; 2020 Jul; 13(7):755-769. PubMed ID: 32419532
[TBL] [Abstract][Full Text] [Related]
35. Central nervous system relapse in children with acute lymphoblastic leukemia.
Bleyer WA; Tubergen DG
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):673-4. PubMed ID: 7852135
[No Abstract] [Full Text] [Related]
36. [Molecular biology in childhood acute lymphoblastic leukemia (ALL)].
Manabe A
Rinsho Ketsueki; 2013 Oct; 54(10):1999-2005. PubMed ID: 24064854
[No Abstract] [Full Text] [Related]
37. [Acute lymphoblastic leukemia (ALL)].
Manabe A
Nihon Rinsho; 2012 Apr; 70 Suppl 2():670-5. PubMed ID: 23134026
[No Abstract] [Full Text] [Related]
38. Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment.
Silverman LB; Sallan SE
Curr Opin Hematol; 2003 Jul; 10(4):290-6. PubMed ID: 12799535
[TBL] [Abstract][Full Text] [Related]
39. Repeats in the kringle IV encoding domains in the Apo(a) gene and serum lipoprotein(a) level do not contribute to the risk for avascular necrosis of the bone (AVN) in pediatric acute lymphoblastic leukemia.
van Beek RD; Bezemer DD; Meijerink JP; de Muinck Keizer-Schrama SM; Haas OA; Te Winkel L; Pieters R; van den Heuvel-Eibrink M
Leukemia; 2006 May; 20(5):879-80. PubMed ID: 16525499
[No Abstract] [Full Text] [Related]
40. MicroRNA expression and activity in pediatric acute lymphoblastic leukemia (ALL).
de Oliveira JC; Brassesco MS; Scrideli CA; Tone LG; Narendran A
Pediatr Blood Cancer; 2012 Oct; 59(4):599-604. PubMed ID: 22492670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
